{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T12:35:16Z","timestamp":1723293316154},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.2169\/internalmedicine.2891-23","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T22:11:00Z","timestamp":1704147060000},"page":"809-814","source":"Crossref","is-referenced-by-count":2,"title":["An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"63","author":[{"given":"Takahito","family":"Shimada","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, JA Gifu Koseiren Gifu\/Seino Medical Center Nishimino Kosei Hospital, Japan"},{"name":"Department of Gastroenterology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JA Gifu Koseiren Gifu\/Seino Medical Center Nishimino Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Iwashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JA Gifu Koseiren Gifu\/Seino Medical Center Nishimino Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JA Gifu Koseiren Gifu\/Seino Medical Center Nishimino Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JA Gifu Koseiren Gifu\/Seino Medical Center Nishimino Kosei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Morens DM, Daszak P, Taubenberger JK. Escaping Pandora's box - another novel coronavirus. N Engl J Med 382: 1293-1295, 2020.","DOI":"10.1056\/NEJMp2002106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Du M, Cai G, Chen F, Christiani CC, Zhang Z, Wang M. Multiomics evaluation of gastrointestinal and other clinical characteristics of COVID-19. Gastroenterology 158: 2298-2301.e7, 2020.","DOI":"10.1053\/j.gastro.2020.03.045"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wong H-L, Hu M, Zhou CK, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet 399: 2191-2199, 2022.","DOI":"10.1016\/S0140-6736(22)00791-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimodaira Y, Watanabe K, Takahashi S, Koizumi S, Iijima K. Inflammatory bowel disease triggered by BNT162b2 mRNA vaccination for SARS-CoV-2. Inflamm Bowel Dis 28: e75, 2022.","DOI":"10.1093\/ibd\/izab297"},{"key":"5","unstructured":"5. Takahashi Y, Shimodaira Y, Yoshida T, et al. A case of severe inflammatory bowel disease triggered by vaccination with SARS-CoV-2 mRNA. Nihon Shokakibyo Gakkai Zasshi (J Jpn Soc Gastroenterol) 120: 325-329, 2023 (in Japanese, Abstract in English)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cagatay AK, Suleyman S, Gupse A, Kamil O. Acute severe ulcerative colitis after mRNA coronavirus disease 2019 vaccination: can mRNA vaccines unmask inflammatory bowel diseases? ACG Case Rep J 9: e00806, 2022.","DOI":"10.14309\/crj.0000000000000806"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kothadia S, Ward C, Akerman P. New diagnosis of severe ulcerative colitis immediately following mRNA-1273 SARS-CoV2 vaccination. Am J Gastroenterol 116: S1027, 2021.","DOI":"10.14309\/01.ajg.0000783228.57948.29"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kuo HL, Lin TY, Leong PY. Case report of new-onset ulcerative colitis after MVC-COVI1901 vaccine injection for SARS-CoV-2. Int J Rheum Dis 26: 1594-1598, 2023.","DOI":"10.1111\/1756-185X.14637"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56: 489-526, 2021.","DOI":"10.1007\/s00535-021-01784-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takahashi H, Matsui T, Hisabe T, et al. Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation. J Gastroenterol Hepatol 29: 1603-1608, 2014.","DOI":"10.1111\/jgh.12616"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Surawicz CM, Haggitt RC, Husseman M, Mcfarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 107: 755-763, 1994.","DOI":"10.1016\/0016-5085(94)90124-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol 15: 586-594, 2018.","DOI":"10.1038\/cmi.2017.151"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 217: 108480, 2020.","DOI":"10.1016\/j.clim.2020.108480"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Trougakos IP, Terpos E, Alexopoulos H, et al. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med 28: 542-554, 2022.","DOI":"10.1016\/j.molmed.2022.04.007"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Weaver KN, Zhang X, Dai X, et al. Impact of SARS-CoV-2 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: results from PREVENT-COVID. Inflamm Bowel Dis 28: 1497-1505, 2022.","DOI":"10.1093\/ibd\/izab302"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lev-Tzion R, Focht G, Lujan R, et al. COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation. Clin Gastroenterol Hepatol 20: e1263-e1282, 2022.","DOI":"10.1016\/j.cgh.2021.12.026"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Guillaume PC, Luc D, Corinne GR, Antoine C, Jean-Fr\u00e9d\u00e9ric C, Laurent PB. Vaccination and risk for developing inflammatory bowel disease: a meta-analysis of case-control and cohort studies. Clin Gastroenterol Hepatol 13: 1405-1415, 2015.","DOI":"10.1016\/j.cgh.2015.04.179"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_2891-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:31:45Z","timestamp":1715574705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/6\/63_2891-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2891-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"2891-23"}}